Ulf Carl Magnus Boberg
Chief Executive Officer at CREATIVE ANTIBIOTICS SWEDEN AB
Profile
Ulf Carl Magnus Boberg is currently the Chief Executive Officer & Head-Investor Relations at Creative Antibiotics AB since 2012.
Previously, he served as the Chief Executive Officer at Miris Holding AB from 2014 to 2016.
He has also held positions as the Chief Executive Officer at Global Genomics AB, Director at SpectraCure AB and NeoDynamics AB, and SVP-Clinical & Business Development at Affibody AB.
Additionally, Dr. Boberg has worked as the Head-Medical Research at Gambro, Inc. and as the Vice President-Research & Development at AstraZeneca AB.
He started his career as an Investment Manager at CareDx International AB.
Dr. Boberg holds an MBA and a doctorate from the University of Uppsala.
Ulf Carl Magnus Boberg active positions
| Companies | Position | Start |
|---|---|---|
| CREATIVE ANTIBIOTICS SWEDEN AB | Chief Executive Officer | 2010-05-17 |
Former positions of Ulf Carl Magnus Boberg
| Companies | Position | End |
|---|---|---|
| MIRIS HOLDING AB | Chief Executive Officer | 2016-10-03 |
Global Genomics AB
 Global Genomics AB Miscellaneous Commercial ServicesCommercial Services Global Genomics AB used to discovers disease genes, drug targets and disease-associated biomarkers. It was also developing and out-licenses proprietary tools in functional genomics that provide insight into healthy, diseased or drug-treated cells. The company was founded by Patrik Ernfors & Sten Linnarsson in September, 2000 and was located in Stockholm, Sweden. | President | 2005-11-29 |
| NEOS AB | Director/Board Member | - |
| SPECTRACURE AB | Director/Board Member | - |
| ALLENEX AB | Chief Investment Officer | - |
Training of Ulf Carl Magnus Boberg
| University of Uppsala | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MIRIS HOLDING AB | Electronic Technology |
| SPECTRACURE AB | Electronic Technology |
| NEOS AB | Health Technology |
| Private companies | 6 |
|---|---|
Creative Antibiotics AB
 Creative Antibiotics AB Pharmaceuticals: MajorHealth Technology Creative Antibiotics AB engages in the manufacture of pharmaceuticals products. The company was founded in 2000 and is headquartered in Umeå, Sweden. | Health Technology |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Commercial Services |
Gambro, Inc.
 Gambro, Inc. Medical/Nursing ServicesHealth Services Gambro, Inc. provides medical technology and healthcare services. It offers renal care services, products and blood component technology. The company develops and supplies hemodialysis, peritoneal and acute dialysis products. Gambro was founded by Kevin M. Smith in 1968 and is headquartered in Lakewood, CO. | Health Services |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
CareDx International AB
 CareDx International AB BiotechnologyHealth Technology CareDx International AB engages in the development, manufacture, and sale of products for transplantation of blood stem cells and organs. It offers tissue typing products and products for antibody detection. The company was founded by Ingemar Lagerlöf in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
Global Genomics AB
Global Genomics AB Miscellaneous Commercial ServicesCommercial Services Global Genomics AB used to discovers disease genes, drug targets and disease-associated biomarkers. It was also developing and out-licenses proprietary tools in functional genomics that provide insight into healthy, diseased or drug-treated cells. The company was founded by Patrik Ernfors & Sten Linnarsson in September, 2000 and was located in Stockholm, Sweden. | Commercial Services |
- Stock Market
- Insiders
- Ulf Carl Magnus Boberg
